Overview
Properties
Constituents: 25% Glycerol, 50mM Tris HCl, 150mM Sodium chloride, 0.25mM DTT, 0.1mM PMSF, pH 7.5
Concentration information loading...Applications
Our Abpromise guarantee covers the use of ab56272 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| SDS-PAGE | SDS-PAGE: Use at an assay dependent dilution. |
Protein info
-
Alternative names
- CBPCBP/p300CBP_HUMAN
- CREB binding proteinCREB-binding proteinCREBBPCyclic AMP responsive enhancer binding proteinKAT3ARSTSRTSRubinstein Taybi syndrome
see all
Defects in CREBBP are a cause of Rubinstein-Taybi syndrome type 1 (RSTS1) [MIM:180849]. RSTS1 is an autosomal dominant disorder characterized by craniofacial abnormalities, broad thumbs, broad big toes, mental retardation and a propensity for development of malignancies.
Contains 1 KIX domain.
Contains 2 TAZ-type zinc fingers.
Contains 1 ZZ-type zinc finger.
modificationsMethylation of the KIX domain by CARM1 blocks association with CREB. This results in the blockade of CREB signaling, and in activation of apoptotic response.
Phosphorylated upon DNA damage, probably by ATM or ATR.
Sumoylation negatively regulates transcriptional activity via the recruitment of DAAX.
Target information above from: UniProt accession
Q92793
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010)
.
References for KAT3A / CBP protein (Tagged) (ab56272)
ab56272 has not yet been referenced specifically in any publications.
